← Privia Health Group, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $786.4m |
$817.1m
+3.91%
|
$966.2m
+18.25%
|
$1.4b
+40.41%
|
$1.7b
+22.19%
|
$1.7b
+4.74%
|
$2.1b
+22.26%
|
$477.4m
-77.51%
|
$2.4b
+393.95%
|
|
| Cost of revenues | — | $196.0m |
$204.6m
+4.38%
|
$321.7m
+57.23%
|
$370.9m
+15.29%
|
$341.8m
-7.85%
|
$317.3m
-7.16%
|
$315.3m
-0.64%
|
$2.1b
+572.85%
|
|
| Cost Of Revenue | — | — | — | $1.2b |
$1.5b
+22.45%
|
$1.6b
+4.23%
|
$1.9b
+22.69%
|
— | $2.1b | |
| Gross margin | — | $83.0m |
$83.0m
+0.05%
|
$116.2m
+39.91%
|
$151.8m
+30.67%
|
$149.3m
-1.62%
|
$156.1m
+4.57%
|
$162.1m
+3.81%
|
$236.5m
+45.93%
|
|
| Net Interest Income | — | ($1.9m) | ($1.1m) |
$542k
+150.65%
|
$8.4m
+1444.65%
|
$10.9m
+30.05%
|
$9.7m
-10.88%
|
— | $7.9m | |
| Gross Profit | — | $83.0m |
$83.0m
+0.05%
|
$134.8m
+62.35%
|
$161.5m
+19.82%
|
$176.9m
+9.51%
|
$209.4m
+18.42%
|
$162.1m
-22.61%
|
$236.5m
+45.93%
|
|
| Interest Income (Expense), Net | — | ($1.9m) | ($1.1m) |
$542k
+150.65%
|
$8.4m
+1444.65%
|
$10.9m
+30.05%
|
$9.7m
-10.88%
|
— | — | |
| Sales and marketing | $9.2m | $11.3m | $22.8m | $19.7m | $24.7m | $26.4m | $27.1m | — | — | |
| Selling, general and administrative expenses | — | $76.8m | $81.7m | $98.8m | $126.5m | $121.6m | $116.1m | $122.2m | $179.6m | |
| Amortization of Intangible Assets | — | $642k | $1.3m | $3.4m | $5.4m | $6.2m | $9.2m | — | — | |
| Amortization of intangibles | — | $11.3m | $11.7m | $14.3m | $27.5m | $23.1m | $18.9m | $18.6m | — | |
| Operating Expenses | $770.3m | $791.7m | $1.2b | $1.4b | $1.6b | $1.7b | $2.1b | $190.2m | $191.6m | |
| Operating Income (Loss) | $16.1m |
$25.4m
+58.01%
|
($217.4m)
-956.72%
|
($19.1m)
+91.21%
|
$20.6m
+207.99%
|
$17.0m
-17.76%
|
$34.2m
+101.60%
|
($28.1m)
-182.06%
|
$44.9m
+259.74%
|
|
| Interest Expense | — | $1.9m | $1.1m | $500k | — | — | — | — | — | |
| Interest income, net | — | ($1.9m) | ($1.1m) | $542k | $8.4m | $10.9m | $9.7m | — | — | |
| Net Non Operating Interest Income Expense | — | ($1.9m) | ($1.1m) | $542k | $8.4m | $10.9m | $9.7m | — | $7.9m | |
| (Loss) earnings before income taxes | — | ($42.6m) | ($19.6m) | ($18.6m) | ($36.4m) | ($16.6m) | $4.1m | ($37.6m) | — | |
| Pre-Tax Income | $9.2m | $23.5m | ($218.5m) | ($18.6m) | $29.0m | $27.9m | $43.9m | — | $56.1m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $9.2m | $23.5m | ($218.5m) | ($18.6m) | $29.0m | $27.9m | $43.9m | — | $56.1m | |
| Provision for income taxes | $1.2m | ($7.4m) | ($27.9m) | ($6.5m) | $8.0m | $10.8m | $14.2m | — | — | |
| Effective income tax rate | — | ($3.0m) | ($2.3m) | ($3.0m) | ($6.3m) | $61k | $2.8m | $1.2m | — | |
| Net Income From Continuing And Discontinued Operation | $7.9m | $31.2m | ($188.2m) | ($8.6m) | $23.1m | $14.4m | $22.9m | — | $28.1m | |
| Less: Net income (loss) attributable to non-controlling interests | ($299k) | ($340k) | ($2.4m) | ($3.5m) | ($2.1m) | $2.7m | $6.8m | — | — | |
| Net Income Continuous Operations | — | — | — | ($12.1m) | $21.0m | $17.0m | $29.7m | — | $33.8m | |
| Earnings Per Share, Basic | $0.09 | $0.33 | ($1.83) | ($0.08) | $0.20 | $0.12 | $0.19 | ($0.40) | $0.23 | |
| Earnings Per Share, Diluted | $0.09 | $0.33 | ($1.83) | ($0.08) | $0.19 | $0.11 | $0.18 | ($0.40) | $0.22 | |
| Weighted Average Number of Shares Outstanding, Basic | 95.9m | 96.0m | 103.0m | 110.7m | 116.7m | 119.4m | 122.2m | — | 124.1m | |
| Weighted average common shares outstanding - basic (in shares) | 95.9m | 96.0m | 103.0m | 110.7m | 116.7m | 119.4m | 122.2m | — | — | |
| Weighted average common shares outstanding – diluted (in shares) | 95.9m | 96.0m | 103.0m | 110.7m | 124.7m | 125.6m | 128.9m | — | — | |
| Basic Average Shares | 95.9m | 96.0m | 103.0m | $110.7m | $116.7m | $119.4m | $122.2m | — | $124.1m | |
| Diluted Average Shares | 95.9m | 96.0m | 103.0m | $110.7m | $124.7m | $125.6m | $128.9m | — | $130.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | 95.9m | 96.0m | 103.0m | 110.7m | 124.7m | 125.6m | 128.9m | — | 130.5m | |
| Additional Financial Items | ||||||||||
| Goodwill, Impairment Loss | — | $0 | $0 | $0 | — | — | — | — | — | |
| Depreciation and amortization | $1.4m | $1.8m | $2.5m | $4.6m | $6.5m | $7.3m | $9.9m | $3.5m | $12.1m | |
| Impairment loss | — | — | — | — | — | — | $5.1m | $41.1m | — | |
| Foreign exchange loss (gain) | — | ($161k) | $473k | ($26k) | $159k | $102k | ($258k) | $674k | — | |
| Current | — | $237k | $1.5m | ($20k) | $569k | $317k | $1.3m | $2.7m | $22.3m | |
| Deferred | — | ($3.2m) | ($3.8m) | ($3.0m) | ($6.8m) | ($256k) | $1.5m | ($1.5m) | — | |
| Net (loss) earnings | — | ($39.7m) | ($17.3m) | ($15.5m) | ($30.1m) | ($16.7m) | $1.3m | ($38.8m) | — | |
| Cumulative translation adjustment on consolidation of foreign subsidiaries | — | — | ($6.6m) | ($439k) | $5.6m | ($4k) | $3.4m | ($1.9m) | — | |
| Comprehensive (loss) income | — | — | ($24.0m) | ($16.0m) | ($24.5m) | ($16.7m) | $4.7m | ($40.7m) | — | |
| Impairment of goodwill | — | — | — | — | — | $0 | $5.1m | — | — | |
| Gain on recovery of note receivable | — | $0 | ($660k) | $0 | — | — | — | — | — | |
| Impairment of intangibles and goodwill | — | $28.0m | $0 | — | — | — | — | — | — | |
| Profit (loss) from operating activities | — | ($41.0m) | ($17.0m) | — | — | — | — | — | — | |
| Gains (losses) recognised when control of subsidiary is lost | — | ($681k) | $0 | — | — | — | — | — | — | |
| Depreciation Amortization Depletion Income Statement | $1.4m | $1.8m | $2.5m | $4.6m | $6.5m | $7.3m | $9.9m | $3.5m | $12.1m | |
| Diluted EPS | — | — | — | ($0.08) | $0.19 | $0.11 | $0.19 | — | $0.22 | |
| Diluted NI Availto Com Stockholders | $7.9m | $31.2m | ($188.2m) | ($8.6m) | $23.1m | $14.4m | $22.9m | — | $28.1m | |
| Minority Interests | — | — | — | $3.5m | $2.1m | ($2.7m) | ($6.8m) | — | ($5.7m) | |
| Normalized EBITDA | — | — | — | ($14.6m) | $27.2m | $24.2m | $44.1m | — | $56.9m | |
| Normalized Income | $7.9m | $31.2m | ($188.2m) | ($8.6m) | $23.1m | $14.4m | $22.9m | — | $28.1m | |
| Other Gand A | — | — | — | $129.6m | $109.6m | $126.2m | $138.2m | — | — | |
| Reconciled Depreciation | $1.4m | $1.8m | $2.5m | $4.6m | $6.5m | $7.3m | $9.9m | $3.5m | $12.1m | |
| Selling General And Administration | — | — | — | $149.3m | $134.3m | $152.6m | $165.3m | — | — | |
| Tax Effect Of Unusual Items | — | — | — | $0 | $0 | $0 | $0 | — | $0 | |
| Tax Provision | $1.2m | ($7.4m) | ($27.9m) | ($6.5m) | $8.0m | $10.8m | $14.2m | — | $22.3m | |
| Tax Rate For Calcs | — | — | — | $0 | $0 | $0 | $0 | — | $0 | |
| Provider expense | — | $629.5m | $727.8m | $1.1b | $1.3b | $1.3b | $1.7b | — | — | |
| Cost of platform | $95.3m | $105.0m | $174.7m | $170.8m | $197.7m | $227.0m | $252.7m | — | — | |
| Business acquisition, integration and reorganization costs (recovery) | — | — | $2.3m | $11.6m | $18.1m | $3.4m | ($1.2m) | $4.1m | — | |
| Net financial expenses | — | $2.3m | $3.3m | $4.6m | $9.3m | $11.9m | $8.9m | $9.5m | — | |
| Operating expense | — | $123.9m | $100.0m | $130.1m | $178.8m | $154.1m | $175.2m | — | $2.3b | |
| Business Acquisition And Integration Costs | — | $4.6m | $2.3m | — | — | — | — | — | — | |
| Depreciation expense | — | $3.4m | $3.8m | — | — | — | — | — | $12.1m | |
| Total Expenses | $770.3m | $791.7m | $1.2b | $1.4b | $1.6b | $1.7b | $2.1b | $190.2m | $191.6m | |
| Total Other Finance Cost | — | — | — | ($542k) | ($8.4m) | ($10.9m) | ($9.7m) | — | ($9.7m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.